NOVO NORDISK INC. et al v. RIO BIOPHARMACEUTICALS, INC. > Summary
Court Case Number 1:24-cv-00330
Filing Date Jan 19, 2024
Termination Date Jul 29, 2024
Court New Jersey District Court
Status Dismissed - Other
JudgesRenee Marie Bumb, Renee Marie Bumb
Plaintiff
Defendant
Plaintiff Attorneys
4Novo Nordisk
Attorney Name: Alexander Callo
Saul Ewing LLP
Novo Nordisk
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Novo Nordisk
Attorney Name: William C. Baton
Saul Ewing LLP
Novo Nordisk
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Defendant Attorneys
2Rio Biopharmaceuticals, Inc.
Attorney Name: Arnold B. Calmann
Saiber
Rio Biopharmaceuticals, Inc.
Attorney Name: Katherine A. Escanlar
Saiber
Counter Defendant
16Novo Nordisk
Attorney Name: Alexander Callo
Saul Ewing LLP
Novo Nordisk
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Novo Nordisk
Attorney Name: William C. Baton
Saul Ewing LLP
Novo Nordisk
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Novo Nordisk
Attorney Name: Alexander Callo
Saul Ewing LLP
Novo Nordisk
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Novo Nordisk
Attorney Name: William C. Baton
Saul Ewing LLP
Novo Nordisk
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Novo Nordisk
Attorney Name: Alexander Callo
Saul Ewing LLP
Novo Nordisk
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Novo Nordisk
Attorney Name: William C. Baton
Saul Ewing LLP
Novo Nordisk
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Novo Nordisk
Attorney Name: Alexander Callo
Saul Ewing LLP
Novo Nordisk
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Novo Nordisk
Attorney Name: William C. Baton
Saul Ewing LLP
Novo Nordisk
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Counter Claimant
4Rio Biopharmaceuticals, Inc.
Attorney Name: Arnold B. Calmann
Saiber
Rio Biopharmaceuticals, Inc.
Attorney Name: Katherine A. Escanlar
Saiber
Rio Biopharmaceuticals, Inc.
Attorney Name: Arnold B. Calmann
Saiber
Rio Biopharmaceuticals, Inc.
Attorney Name: Katherine A. Escanlar
Saiber
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09265893 | Injection button | Feb 23, 2016 |
| 08114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices | Feb 14, 2012 |
